What is Global Lanthanum Carbonate Market?
The Global Lanthanum Carbonate Market is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. Lanthanum Carbonate is a medication used to lower phosphate levels in patients with kidney disease. It's a white, odorless, and tasteless powder that's insoluble in water. It's primarily used in the treatment of hyperphosphatemia (high blood phosphate levels) in patients with end-stage renal disease. The global market for Lanthanum Carbonate is growing due to the increasing prevalence of kidney diseases and the rising geriatric population. However, the high cost of the drug and the availability of substitutes may hinder the market growth. The market is segmented based on the dosage strength of the drug, which includes 1000mg, 750mg, 500mg, and others.
1000mg, 750mg, 500mg, Other in the Global Lanthanum Carbonate Market:
The Global Lanthanum Carbonate Market is further segmented based on the dosage strength of the drug. The 1000mg dosage is the most commonly prescribed dosage due to its effectiveness in reducing phosphate levels. The 750mg and 500mg dosages are also used, but less frequently. The "other" category includes all other dosage strengths that are less commonly used. The choice of dosage strength depends on the patient's condition and the doctor's prescription. The market for each dosage strength is influenced by factors such as the prevalence of kidney diseases, the effectiveness of the dosage, and the cost of the drug.
Hospital, Pharmacy, Others in the Global Lanthanum Carbonate Market:
The Global Lanthanum Carbonate Market finds its applications mainly in hospitals, pharmacies, and others. Hospitals are the major end-users of Lanthanum Carbonate due to the high number of patients with kidney diseases being treated in hospitals. Pharmacies also hold a significant share of the market as they are the primary point of purchase for the drug. The "others" category includes online pharmacies and direct sales. The market share of each segment is influenced by factors such as the availability of the drug, the number of patients, and the purchasing power of the end-users.
Global Lanthanum Carbonate Market Outlook:
The Global Lanthanum Carbonate Market is expected to grow from US$ 518.8 million in 2022 to US$ 773.4 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period 2023-2029. The market is dominated by two major players who hold about 70% of the global market share. The majority of the market share is held by the hospital segment, which accounts for over 60% of the total market. This growth can be attributed to the increasing prevalence of kidney diseases and the rising geriatric population. However, the high cost of the drug and the availability of substitutes may hinder the market growth.
| Report Metric | Details |
| Report Name | Lanthanum Carbonate Market |
| Accounted market size in 2022 | US$ 518.8 in million |
| Forecasted market size in 2029 | US$ 773.4 million |
| CAGR | 5.8% |
| Base Year | 2022 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| Production by Region |
|
| Consumption by Region |
|
| By Company | Shire Pharmaceuticals, Bayer Health Care, Dr. Reddy's Laboratories, Micro Labs, Wockhardt, Panacea Biotec |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
